Sort
21,281 grants matching “influenza”
Identifying critical determinants of vaccine-induced cellular and humoral immunity from birth through childhood in HIV-exposed and unexposed children
$624,693Jennifer Ann Slyker · University Of Washington · R01 · FY2024 · AI
Thymic Transplantation in Complete DiGeorge Syndrome
$624,631Mary Louise Markert · Duke University · R01 · FY2006 · AI
STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES
$624,606Peter Myler · Seattle Biomedical Research Institute · N01 · FY2017 · AI
Repertoire studies of human antibodies to RSV and MPV F
$624,292Theodore S Jardetzky · Stanford University · R01 · FY2020 · AI
AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease
$624,194Mark T Dransfield · University Of Alabama At Birmingham · UG3 · FY2018 · TR
Mechanism of Ebola Virus Pathogensis and Innate and Adpative Immunity
$624,088Yoshihiro Kawaoka · Oregon Health & Science University · U54 · FY2011 · AI
Influenza virus receptors on human airway epithelial cells
$624,050James C. Paulson · Scripps Research Institute, The · R01 · FY2020 · AI
Influenza vaccine failure in adults over age 75: role of chronic CMV infection
$624,028Sean X Leng · Johns Hopkins University · R01 · FY2017 · AI
Glypicans in Bacterial Lung Infection
$623,861Pyong Woo Park · Boston Children'S Hospital · R01 · FY2025 · HL
Glypicans in Bacterial Lung Infection
$623,861Pyong Woo Park · Boston Children'S Hospital · R01 · FY2024 · HL
Innate NLRC4 signaling controls adaptive immune responses
$623,783Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2024 · AI
Role of preexisting immunity on airborne transmission of influenza viruses
$623,724Seema S. Lakdawala · Emory University · R01 · FY2024 · AI
Influenza DNA Vaccine for Biodefense/Pandemic Readiness
$623,631Powderject Vaccines, Inc. · U01 · FY2003 · AI
The B Cell Insulin Receptor in Health and in Insulin Resistance
$623,556Dan Winer · Buck Institute For Research On Aging · R01 · FY2022 · DK
Advancing immune organoid technology and organoid combinations
$623,357Mark M Davis · Stanford University · U19 · FY2025 · AI
B cell immunity in HIV exposed uninfected infants in Kenya
$623,352Arlene Dent · Case Western Reserve University · R01 · FY2015 · AI
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
$623,280Mark Roberts Looney · University Of California, San Francisco · R01 · FY2022 · AI
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
$623,280Mark Roberts Looney · University Of California, San Francisco · R01 · FY2025 · AI
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
$623,280Mark Roberts Looney · University Of California, San Francisco · R01 · FY2021 · AI
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
$623,280Mark Roberts Looney · University Of California, San Francisco · R01 · FY2024 · AI
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
$623,280Mark Roberts Looney · University Of California, San Francisco · R01 · FY2023 · AI
Vaccination strategies to overcome immune deficiencies in neonates
$623,271Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2012 · AI
Prenatal Factors and Risk of Schizophrenia in a Finnish National Birth Cohort
$623,182Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2012 · MH
Vaccines to Induce Functional Antibodies Targeting the V2 Loop
$623,109Susan B Zolla-Pazner · New York University School Of Medicine · P01 · FY2012 · AI
Recurrent otitis media and COPD: immunity and vaccines
$622,980State University Of New York At Buffalo · P01 · FY2001 · AI